The Anti-VEGF Antibody Bevacizumab Potently Reduces the Growth Rate of High-Risk Neuroblastoma XenograftsLova Segerström, Faranak Azarbayjani|Pediatric Research|2006Cited by 96
Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartmentsD. Fuchs, Faranak Azarbayjani|Journal of Translational Medicine|2009Cited by 8